Sebi approves 4 IPOs including Integris Medtech, Alpine Texworld and Anjali Labtech

Capital markets regulator Sebi has granted approval to four companies to launch their IPOs, paving the way for fresh activity in the primary market pipeline. The cleared proposals include offerings from Integris Medtech, Alpine Texworld, Anjali Labtech and Appl Containers.

Among the four, Integris Medtech is set to launch one of the larger issues. The company, described as the second largest Indian-headquartered diversified medical technology platform in terms of operating revenue for FY25, plans to raise up to Rs 925 crore through a fresh issue of equity shares of face value Re 1 each. The IPO will also include an offer for sale of up to 2,16,74,531 equity shares.

The offer for sale component will see promoter selling shareholders dilute part of their stake. Evercure Holdings will offload up to 1,51,74,251 shares, while Gurmit Singh Chugh and Punita Sharma will each sell up to 32,50,140 shares.

The company has indicated that it may consider a pre-IPO placement of up to Rs 185 crore prior to filing the final prospectus with the Registrar of Companies, in consultation with its book running lead managers.

Net proceeds from the fresh issue are proposed to be used largely for debt reduction. Around Rs 696.39 crore will go towards repayment or prepayment of certain loans, including interest and prepayment charges, availed by its wholly owned subsidiaries and step-down subsidiaries. The balance will be deployed for general corporate purposes.

Alpine Texworld has also received the regulator’s nod for its public issue. The IPO will be structured as a book-built issue comprising entirely a fresh issue of up to 1.50 crore equity shares. The shares are proposed to be listed on both the NSE and BSE. D&A Financial Services has been appointed as the book running lead manager, while Kfin Technologies will act as registrar.
Anjali Labtech, headquartered in Surat, Gujarat, is another company that has secured approval to tap the capital markets. The company operates in the lab-grown diamond segment and is engaged in manufacturing and supplying lab-grown diamonds, lab-grown diamond jewellery, diamond semiconductor materials and Microwave Plasma Chemical Vapour Deposition systems.Its business spans both B2B and B2C markets globally. In addition to jewellery-grade diamonds, Anjali Labtech also manufactures diamond semiconductor substrates used in high-technology applications, as well as MPCVD equipment that enables diamond production. The offering is expected to support expansion plans and strengthen its position in the growing sustainable diamond and advanced materials space.

Appl Containers is the fourth company to receive clearance. The proposed book-built issue comprises 0.38 crore equity shares, including a fresh issue of up to 0.13 crore shares and an offer for sale of up to 0.26 crore shares. The equity shares are proposed to be listed on both NSE and BSE.

Cumulative Capital is the book running lead manager to the issue, while Bigshare Services will serve as registrar.